3 hours Insider Buying: Viridian Therapeutics, Inc. (NASDAQ:VRDN) CEO Acquires 21,400 Shares of Stock MarketBeat
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) CEO Stephen F. Mahoney purchased 21,400 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were purchased at an average cost of $23.33 per share…